Build vs. Outsource

Build vs.

Considerations for deciding to build biostorage capacity in-house versus outsourcing with a trusted partner.

With the increasing value of biological samples and treatment assets, researchers are realizing the importance of centralized biobanking. Whether insourcing on-campus facilities or outsourcing biostorage services, the following investments must be considered:

  • Building specialized, secure facilities with dedicated, scalable storage space
  • Purchasing state-of-the-art equipment
  • Creating global sample management systems
  • Establishing reliable cold chain logistics to transport, handle and process samples between facilities
  • Hiring personnel with specialized expertise needed to effectively operate biorepositories
  • Maintaining staff training, certifications and accreditations
  • Validating equipment, technology and processes
  • Developing and maintaining SOPs, global compliance and business continuity plans
  • Managing global logistics associated with sample centralization

Scisafe’s services range from complete customized outsourced biostorage solutions to hybrid-onsite sample management. Whether you have one or millions of samples, we have the expertise and the facilities to meet your unique needs.

Fully Compliant cGMP Storage Facilities:

  • ISO 9001/ISO 20387
  • FDA registered and inspected since 2011 (CDER and CBER)
  • Over 86 (SOPs) all modeled after FDA (21 CFR parts 210 & 211)
  • GDP (Good Distribution Practices)
storage solutions logo
storage arrow
SciSafe Services logo

Download the White Paper below

SciSafe Build vs Outsource Download

Would you like to be contacted by our sales team?
Would you like to sign up for Biostorage Insights?
This field is for validation purposes and should be left unchanged.

Class-defining solutions for biological and pharmaceutical storage.


This website uses cookies to ensure you get the best experience on our website.